Meet Our Leaders

Adimab’s leadership and board combine scientific excellence, industry insight, and a proven track record of success, providing partners with trusted guidance and a strong foundation for advancing therapeutic discovery.

Tillman U. Gerngross, PhD

Tillman U. Gerngross, PhD

Co-Founder and Executive Chairman of the Board

Philip Chase

Philip Chase

Chief Executive Officer

Eric Krauland, PhD

Eric Krauland, PhD

President and Chief Scientific Officer

Ryan McGovern

Ryan McGovern

Chief Financial Officer

Nancy Thornberry

Nancy Thornberry

Founding CEO and Chair, R&D, Kallyope

Guy Van Meter

Guy Van Meter

Chief Business Officer

Greg Brown

Greg Brown

Chief Executive Officer at Memgen

Terry McGuire

Terry McGuire

Managing Partner, Polaris Partners

Mike Ross, PhD

Mike Ross, PhD

Managing Partner, SV Health Investors

Ajay Royan

Ajay Royan

Founder and Managing General Partner, Mithril Capital Management

Amy Schulman

Amy Schulman

Managing Partner, Polaris Partners

Adimab Royalty Company (ARC) controls the royalty rights to Adimab's most advanced therapeutic programs.